HIV treatment has entered a revolutionary new era, one where a single yearly injection can keep the virus undetectable, and ...
This week, Svante Pääbo, Nobel Prize winner for sequencing the Neanderthal genome, is visiting Estonia. In an interview with ...
A new study describes a key molecular mechanism that explains how cells exchange information through extracellular vesicles ...
Zacks Investment Research on MSN
Can NTLA's In Vivo Pipeline Drive Long-Term Growth Amid Rivalry?
Intellia Therapeutics NTLA has made good progress with the advancement of its in vivo candidate, lonvo-z (or, NTLA-2002), ...
Yas Clinic – Khalifa City, in collaboration with the Abu Dhabi Stem Cells Centre (ADSCC) and Vertex Pharmaceuticals, has ...
A team of researchers have developed a next-generation biological biosensor capable of detecting trace amounts of explosive ...
A new paper from the University of Kansas overturns the idea that a "risk gene" carried by millions of people worldwide ...
6d
A New Way of Stopping High Cholesterol Sounds Like Sci-Fi. Doctors Call it the "Future of Medicine."
New research breaks down how scientists use CRISPR technology to lower cholesterol. The cholesterol-lowering effects could be permanent.
A new paper from the University of Kansas overturns the idea that a "risk gene" carried by millions of people worldwide ...
Developed by UCL spinout Autolus, Aucatzyl will be launched imminently across England and Wales. A UK-developed cell therapy ...
Intellia Therapeutics, Inc. (NASDAQ:NTLA) ranks among the most oversold biotech stocks to invest in. On November 11, Jones ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback